|
2024
|
Invention
|
Phosphinites as reductive disulfide rebridging agents. The present invention generally relates to... |
|
|
Invention
|
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and ... |
|
|
Invention
|
Bispecific antibodies (bsab) binding ltßr and lrrc15. What is described herein relates to an isol... |
|
|
Invention
|
Microcrystalline forms of (r)-2-(n-[4-amino-5-(4-methoxybenzoyl)thiazol-2-yl]-4-fluoroanilino)pro... |
|
|
Invention
|
Combinations of dgk (diacylglycerol kinase) inhibitors and immune checkpoint inhibitors and modul... |
|
|
Invention
|
Combinations of dgk (diacylglycerol kinase) inhibitors. The present invention covers combinations... |
|
|
Invention
|
Combination of ccr8 antibodies with dgk inhibitors in the treatment of cancer. The present invent... |
|
2023
|
Invention
|
Means and methods for diagnosing pancreatic cancer.
The present invention pertains to the field ... |
|
|
Invention
|
Imidazo[4,5-c]quinoline compounds and their use as atm kinase inhibitors.
The present invention ... |
|
|
Invention
|
18f-tagged inhibitors of prostate specific membrane antigen (psma) and their use as imaging agent... |
|
|
Invention
|
Bicyclic triazine derivatives for the treatment of cancer.
The present invention provides compou... |
|
|
Invention
|
Bicyclic triazine derivatives for the treatment of cancer. The present invention provides compoun... |
|
2022
|
Invention
|
Substituted aminoquinolones as dgkalpha inhibitors for immune activation. The present invention c... |
|
|
Invention
|
Means and methods for treating and diagnosing fibrosis or fibrosis-associated diseases.
The pres... |
|
|
Invention
|
Means and methods for treating angiogenesis-related diseases.
The present invention is concerned... |
|
|
Invention
|
Substituted aminothiazoles as dgkzeta inhibitors for immune activation. 4 are as defined herein, ... |
|
|
Invention
|
Double-labeled probe for molecular imaging and use thereof. 2 is a spacer or a chemical single bo... |
|
|
Invention
|
2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer. The present ... |
|
|
Invention
|
Receptor tyrosine kinase inhibitors for treatment of protein kinase modulation-responsive disease... |
|
|
Invention
|
Immune enhancers.
The present invention relates to an inhibitor of ubiquitin-specific peptidase ... |
|
|
Invention
|
Immune enhancers. The present invention relates to an inhibitor of ubiquitin-specific peptidase 2... |
|
|
Invention
|
Map4k1 inhibitors.
The present invention relates to Map4K1 inhibitors of formula (I) (I), wherei... |
|
|
Invention
|
Map4k1 inhibitors. The present invention relates to Map4K1 inhibitors of formula (I) (I), wherein... |
|
2021
|
Invention
|
Fusion proteins comprising a binding protein and an interleukin-15 polypeptide having a reduced a... |
|
|
Invention
|
Test system for testing a system for radiologic treatment. A test system (124) for testing a syst... |
|
|
Invention
|
Imidazo[4,5-c]quinoline compounds and their use as atm kinase inhibitors. The present invention r... |
|
|
Invention
|
Optimized method for large scale production of parvovirus h-1 in an essentially serum-free medium... |
|
|
Invention
|
Casp8ap2 antagonists for use in the prevention or treatment of cancer.
The present invention pro... |
|
|
Invention
|
Pyrazolopyrazines acting on cancers via inhibition of cdk12.
The present invention provides comp... |
|
|
Invention
|
Imidazotriazines acting on cancer via inhibition of cdk12.
The present invention provides compou... |
|
2020
|
Invention
|
Pyrazolotriazines.
The present invention provides compounds of general formula (I), in which X, ... |
|
|
Invention
|
Kit for a fiducial marker-based registration of preinterventional image data to an intra-interven... |
|
|
Invention
|
Substituted aminoquinolones as dgkalpha inhibitors for immune activation.
The present invention ... |
|
|
Invention
|
Compounds for preventing migration of cancer cells.
The present invention relates to a compositi... |
|
|
Invention
|
[1,2,4]triazolo[1,5-c]quinazolin-5-amines.
The present invention covers [1,2,4]triazolo[1,5-c]qu... |
|
|
Invention
|
Inhibition of metastasis development by nangptl-4.
The present invention relates to an N-termina... |
|
|
Invention
|
Polypeptides for treatment of aml.
The present invention relates to a polypeptide comprising (i)... |
|
|
Invention
|
Device and a method for monitoring a treatment of a body part of a patient with particles. A devi... |
|
|
Invention
|
Improving cas nuclease target specificity.
The present invention relates to a method for modifyi... |
|
|
Invention
|
Plasmodium antibodies.
The present invention relates to an antibody binding to a peptide compris... |
|
|
Invention
|
Sphingolipids for generating regulatory cd4+ t cells.
The present invention relates to a substan... |
|
|
Invention
|
Novel inhibitors of histone deacetylase 10.
The present invention relates to novel inhibitors of... |
|
|
Invention
|
Expression constructs for the genetic modification of cells.
The present invention relates to a ... |
|
|
Invention
|
Prostate specific membrane antigen (psma) ligands comprising an amylase cleavable linker.
In par... |
|
|
Invention
|
Prostate specific membrane antigen (psma) ligands with improved tissue specificity.
The present ... |
|
|
Invention
|
Substituted pyrrolopyridine-derivatives. 4b are as defined herein, to pharmaceutical compositions... |
|
2018
|
Invention
|
2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer.
The present... |
